Latest / AI Investment Edge: Stocks, Markets & Money / Northrop Grumman: Record Backlog, Tough Delivery | EP026
Transcript
- 0:00SPEAKER_00: If someone told you they had a guaranteed $110 billion sitting in
- 0:06SPEAKER_00: a vault just waiting for them, you'd probably think they had it made, right?
- 0:11SPEAKER_01: Oh, absolutely.
- 0:12SPEAKER_00: Zero financial stress.
- 0:13SPEAKER_01: You'd think they could just kick back.
- 0:14SPEAKER_00: Exactly.
- 0:15SPEAKER_00: Zero financial stress.
- 0:17SPEAKER_00: But imagine that vault is locked,
- 0:19SPEAKER_00: and the only way to get the money out piece by piece is
- 0:23SPEAKER_00: by successfully building some of the most complex,
- 0:25SPEAKER_00: highly engineered machinery in human history.
- 0:28SPEAKER_01: Yeah, it really is the ultimate corporate mirage.
- 0:30SPEAKER_01: I mean, the money is there on paper, sure.
- 0:33SPEAKER_01: But turning a massive order book into actual cash in the bank is just
- 0:37SPEAKER_01: a totally different reality.
- 0:39SPEAKER_00: And that is the massive puzzle we are unraveling today.
- 0:42SPEAKER_00: So Northrop Grumman is sitting on a record $110 billion backlog.
- 0:47SPEAKER_00: But getting that money out of the vault is, well, it's no easy task.
- 0:52SPEAKER_00: And hey, if you're a newcomer to our deep dives, we are incredibly glad you're here.
- 0:56SPEAKER_01: Glad to have you.
- 0:57SPEAKER_00: Today, we're unpacking a specific research brief from iPulse AI,
- 1:01SPEAKER_00: and it's titled AI Investment Edge.
- 1:04SPEAKER_00: We have Northrop's Q3 earnings release,
- 1:06SPEAKER_00: we've got data research models,
- 1:08SPEAKER_00: and a ton of financial data to help you figure out
- 1:10SPEAKER_00: if they can actually turn those paper promises into cash for investors.
- 1:15SPEAKER_01: Right, and to set the baseline here, Northrop Grumman is just a titan in defense and aerospace.
- 1:20SPEAKER_01: They develop and support stealth aircraft, strategic missiles, sensors.
- 1:23SPEAKER_00: Communications, right?
- 1:24SPEAKER_01: Yeah, communications and space systems.
- 1:26SPEAKER_01: And their primary customer is obviously the US government.
- 1:29SPEAKER_01: They are heavily focused on key nuclear modernization programs,
- 1:33SPEAKER_01: specifically the B-21 Raider and the Sentinel Intercontinental Ballistic Missile.
- 1:38SPEAKER_00: But there is a crucial distinction we have to make right up front
- 1:41SPEAKER_00: about how they actually get paid.
- 1:43SPEAKER_00: Because revenue is recognized as the work is performed on those programs.
- 1:48SPEAKER_00: But the payments they receive and the actual profit they book.
- 1:51SPEAKER_01: Yeah, that's the catch.
- 1:52SPEAKER_00: Right.
- 1:52SPEAKER_00: That depends strictly on their contract terms and successful delivery.
- 1:57SPEAKER_01: Which is exactly what the internal research models at iPulse AI are evaluating.
- 2:02SPEAKER_01: The models released in September assigned early dated by labels
- 2:06SPEAKER_01: at both their one year and five year marks.
- 2:08SPEAKER_00: Okay.
- 2:09SPEAKER_01: And it is important for you to note those periods end on 18 September 2027 and 2031.
- 2:15SPEAKER_01: These are fixed endpoints and original dated labels.
- 2:18SPEAKER_01: I mean, this is not a brand new rating generated five minutes after today's Q3 results dropped.
- 2:23SPEAKER_00: Got it.
- 2:24SPEAKER_00: So we are looking at how today's Q3 updates map onto that existing September evidence.
- 2:30SPEAKER_00: Now, the research highlights four distinct financial findings.
- 2:33SPEAKER_01: Yeah, let's get into those.
- 2:34SPEAKER_00: The first one is all about earnings.
- 2:37SPEAKER_00: Sales rose 7% to about $11.1 billion, and that was aided by some tax credits.
- 2:42SPEAKER_01: Which proves that customer demand is successfully converting into revenue.
- 2:46SPEAKER_01: However, sales alone do not explain the per share profit.
- 2:50SPEAKER_01: Because of the margins.
- 2:51SPEAKER_01: Exactly.
- 2:52SPEAKER_01: You can sell more volume,
- 2:53SPEAKER_01: but if the tax rate or the underlying profitability of those sales shifts,
- 2:57SPEAKER_01: well, the bottom line per share number tells a different story entirely.
- 3:01SPEAKER_00: So they are making more sales, but are they actually making more money on those sales?
- 3:05SPEAKER_00: Because looking at finding number two, their margins tell a really interesting story.
- 3:09SPEAKER_01: They do.
- 3:09SPEAKER_00: Their segment operating profit dollars actually rose 5%.
- 3:13SPEAKER_00: But the profit margin,
- 3:14SPEAKER_00: like the actual share of revenue they retained,
- 3:17SPEAKER_00: it actually eased down to 12.1% from 12.3%.
- 3:21SPEAKER_01: Right.
- 3:22SPEAKER_01: And to understand why the margin compressed slightly,
- 3:24SPEAKER_01: we have to look at the exact reported explanations.
- 3:27SPEAKER_01: This was principally due to a favorable contract adjustment
- 3:30SPEAKER_01: in their mission system segment during the prior year comparison.
- 3:34SPEAKER_00: So last year just looked a bit stronger in that segment.
- 3:36SPEAKER_01: Precisely.
- 3:38SPEAKER_01: And that was partially offset by improvements in the aeronautics segment,
- 3:41SPEAKER_01: but then a shifting defense contract mix affected the overall margin.
- 3:46SPEAKER_00: Okay, and we need to clarify what we mean by segment operating profit because it's
- 3:51SPEAKER_00: a non-gap measure, right?
- 3:52SPEAKER_01: Right, it is.
- 3:53SPEAKER_01: The precise non-gap scope here retains the pension costs allocated to the sectors
- 3:57SPEAKER_01: under government contract accounting,
- 3:59SPEAKER_01: but it explicitly excludes certain corporate items and it excludes
- 4:03SPEAKER_01: the company level financial accounting pension adjustment.
- 4:07SPEAKER_01: The research advises you to use the reported segment result directly to get
- 4:10SPEAKER_01: the clearest picture of their operational performance.
- 4:13SPEAKER_00: Makes sense.
- 4:14SPEAKER_00: So finding number three looks at the balance sheet.
- 4:17SPEAKER_00: They are sitting on about $3.7 billion in cash against $15 billion in debt.
- 4:23SPEAKER_01: Which is significant.
- 4:24SPEAKER_00: Cash, operating receipts,
- 4:26SPEAKER_00: and their ability to borrow certainly support the ongoing business,
- 4:30SPEAKER_00: but working capital requirements and debt service still deeply matter.
- 4:34SPEAKER_01: Especially when you are financing massive production cycles, right?
- 4:37SPEAKER_00: Oh, absolutely.
- 4:38SPEAKER_01: Especially before the customer fully pays out.
- 4:40SPEAKER_00: Which feeds perfectly into finding number four, which is investment.
- 4:45SPEAKER_00: They have roughly $2.5 billion tied up in company-funded capacity investment for
- 4:50SPEAKER_00: the B-21 program spanning multiple years.
- 4:53SPEAKER_01: And this circles right back to your opening thought about the vault.
- 4:56SPEAKER_01: The returns on that $2.5 billion investment depend entirely on successful delivery
- 5:02SPEAKER_01: after that spending occurs.
- 5:04SPEAKER_01: You fund the capacity today,
- 5:05SPEAKER_01: but you only get the real payback if those bombers actually roll off
- 5:08SPEAKER_01: the line profitably tomorrow.
- 5:10SPEAKER_00: Okay, let's unpack this.
- 5:12SPEAKER_00: Because if they are spending billions on new factories and capacity,
- 5:16SPEAKER_00: how are they not bleeding cash right now?
- 5:19SPEAKER_00: The brief lays out a single cash bridge, and I think the proportions here are the real insight.
- 5:24SPEAKER_01: Yeah, the math is vital here.
- 5:26SPEAKER_01: You start with roughly $1.7 billion in operating cash,
- 5:29SPEAKER_01: subtract $300 million for investment,
- 5:32SPEAKER_01: and that leaves about $1.4 billion in positive cash after CapEx.
- 5:36SPEAKER_00: So their core operations are generating positive cash before anything else happens.
- 5:40SPEAKER_01: Yes.
- 5:41SPEAKER_00: But then there's an addition from an asset sale, right?
- 5:45SPEAKER_01: There is.
- 5:46SPEAKER_01: You add the customer equipment sale proceeds and note this carefully.
- 5:50SPEAKER_01: It is about $0.4 billion.
- 5:53SPEAKER_01: That is $400 million, which is notably smaller than $1 billion.
- 5:59SPEAKER_01: Adding that brings the total to about $1.8 billion in company adjusted free cash flow.
- 6:04SPEAKER_00: Got it.
- 6:04SPEAKER_00: And the company includes this legitimate equipment sale in their definition.
- 6:08SPEAKER_00: So it is a valid metric.
- 6:10SPEAKER_00: But the key takeaway for you listening is that the underlying cash
- 6:14SPEAKER_00: after CapEx was already positive at $1.4 billion before that sale.
- 6:19SPEAKER_01: Exactly.
- 6:20SPEAKER_00: Moving forward, we'll just refer to it as the disclosed equipment sale.
- 6:24SPEAKER_01: Yeah.
- 6:24SPEAKER_01: You always separate operating cash from asset sale proceeds
- 6:28SPEAKER_01: when assessing how repeatable a company's cash flow actually is.
- 6:32SPEAKER_00: It totally reminds me of our conversation back in episode 13 when we looked at NVIDIA.
- 6:37SPEAKER_01: Oh, yeah.
- 6:38SPEAKER_01: That's a great comparison.
- 6:39SPEAKER_00: Right.
- 6:39SPEAKER_00: We examined how their receivables and inventory were absorbing cash despite
- 6:44SPEAKER_00: the massive reported profit they had.
- 6:46SPEAKER_00: Obviously, building stealth bombers and AI chips are completely different businesses.
- 6:50SPEAKER_01: Completely different.
- 6:51SPEAKER_00: But there is the exact same critical need to distinguish booked earnings from collected cash.
- 6:57SPEAKER_01: Because profit on an income statement does not pay the bills.
- 7:01SPEAKER_01: Collected cash pays the bills.
- 7:03SPEAKER_01: So how does this cash generation impact the valuation?
- 7:07SPEAKER_01: The recording reference price for this analysis is roughly $511 per share.
- 7:12SPEAKER_00: And that's from the last available IEX trade in New York on October 19th.
- 7:17SPEAKER_01: Correct.
- 7:17SPEAKER_00: And just for accuracy, that's a reference point, not a certified consolidated close.
- 7:22SPEAKER_01: From that roughly $511 reference, the AI model evaluated all the evidence.
- 7:29SPEAKER_01: Its base path projects roughly 14% and 62% cumulative price appreciation
- 7:34SPEAKER_01: to those two fixed endpoints we mentioned earlier.
- 7:37SPEAKER_00: Just to be clear for everyone, those are cumulative returns, not annualized.
- 7:40SPEAKER_01: Exactly.
- 7:42SPEAKER_00: And those research weights are an aggregate judgment from the AI framework.
- 7:45SPEAKER_00: They are not strict case probabilities.
- 7:47SPEAKER_00: And we also have to factor in the dividends because
- 7:49SPEAKER_00: that is tangible cash handed back to the investor.
- 7:53SPEAKER_00: Their latest ordinary dividend is roughly $2.50 per share quarterly.
- 7:58SPEAKER_00: Using an unchanged rate illustration,
- 7:59SPEAKER_00: that is about $9.9 over four future payments and $49 over 20 payments.
- 8:06SPEAKER_01: Right.
- 8:06SPEAKER_01: And when you include that dividend cash,
- 8:08SPEAKER_01: those base returns shift to around 16% and 72% gross before taxes or fees
- 8:14SPEAKER_01: without reinvestment.
- 8:16SPEAKER_00: The brief also outlines qualitative bull and bear cases without the numerical endpoints.
- 8:21SPEAKER_00: For the bull case,
- 8:22SPEAKER_00: the upside drivers are better factory throughput,
- 8:24SPEAKER_00: fewer unfavorable cost revisions, and highly productive capacity.
- 8:28SPEAKER_01: Basically, the manufacturing machine hums perfectly.
- 8:31SPEAKER_00: Right.
- 8:32SPEAKER_00: And conversely,
- 8:32SPEAKER_00: the bear case involves sustained high investment without the cash payoff,
- 8:36SPEAKER_00: unfavorable contract cost revisions,
- 8:39SPEAKER_00: government funding delays, or slower cash collections.
- 8:42SPEAKER_01: Which brings up the ongoing frictions versus the drivers.
- 8:45SPEAKER_01: The drivers make sense, you know.
- 8:46SPEAKER_01: The government demands strategic programs, inventory replenishment, and specialized engineering.
- 8:52SPEAKER_00: But the frictions are intense.
- 8:54SPEAKER_00: Labor shortages,
- 8:55SPEAKER_00: supplier bottlenecks,
- 8:56SPEAKER_00: rising production costs, and unpredictable government budget timing.
- 9:01SPEAKER_01: And this is where that massive order book gets extremely complicated.
- 9:05SPEAKER_00: Wait, hold on.
- 9:06SPEAKER_00: So this record $110 billion backlog, it's mostly expected future contracted sales.
- 9:13SPEAKER_00: And roughly half of it isn't even funded yet.
- 9:16SPEAKER_00: It's not guaranteed profit or bank cash.
- 9:18SPEAKER_01: That is absolutely correct.
- 9:19SPEAKER_01: It creates conditional tails on both sides.
- 9:22SPEAKER_01: The upside tail contains conditional possibilities,
- 9:25SPEAKER_01: like the government deciding to procure a larger bomber fleet
- 9:28SPEAKER_01: or Northrop winning major missile defense awards.
- 9:31SPEAKER_00: Okay, and the downside tail.
- 9:33SPEAKER_01: A severe test failure or a major procurement reduction that disrupts years of anticipated work.
- 9:39SPEAKER_01: To be clear,
- 9:39SPEAKER_01: these are conditional risks,
- 9:41SPEAKER_01: not newly reported failures, but they do loom over the backlog.
- 9:45SPEAKER_00: Wow.
- 9:45SPEAKER_00: Yeah.
- 9:46SPEAKER_00: This friction between grand engineering ambition
- 9:49SPEAKER_00: and actual cash generation is giving me major flashbacks
- 9:52SPEAKER_00: to our episode 23 conversation on SpaceX.
- 9:56SPEAKER_01: It is a highly relevant contrast.
- 9:58SPEAKER_01: When we looked at SpaceX,
- 10:00SPEAKER_01: we saw a profitable connectivity segment operating inside
- 10:03SPEAKER_01: a much wider heavy investment program with a large group cash investment gap.
- 10:08SPEAKER_00: Right.
- 10:09SPEAKER_00: SpaceX was not a self-funding group and they had both government and commercial customers.
- 10:13SPEAKER_01: Exactly.
- 10:14SPEAKER_01: When you compare SpaceX's engineering ambition and cash payback to Northrop's,
- 10:18SPEAKER_01: you see the similarities.
- 10:20SPEAKER_01: But you must keep the businesses distinct without inventing any funding models for them.
- 10:25SPEAKER_01: Northrop relies almost entirely on a single sovereign customer
- 10:28SPEAKER_01: for generational defense platforms.
- 10:30SPEAKER_00: Which brings us to the core of the internal research's possible mispricing thesis,
- 10:35SPEAKER_00: what they call the alpha gap.
- 10:37SPEAKER_00: What exactly are the models seeing here?
- 10:39SPEAKER_01: Well, the hypothesis from the September models is that Northrop's early costs
- 10:43SPEAKER_01: and heavy factory investments right now might be obscuring much better future
- 10:48SPEAKER_01: production economics.
- 10:49SPEAKER_00: Oh, interesting.
- 10:50SPEAKER_01: Essentially,
- 10:51SPEAKER_01: they are bearing the costs now to build a highly profitable money machine for
- 10:54SPEAKER_01: the 2030s.
- 10:55SPEAKER_00: But the counterpoint,
- 10:57SPEAKER_00: the risk is that the spending just stays high
- 11:00SPEAKER_00: and those economic benefits arrive far too late.
- 11:03SPEAKER_01: That is the central tension.
- 11:04SPEAKER_01: And there is disagreement among the 14 contributions,
- 11:07SPEAKER_01: which span nine framework families and three model versions.
- 11:10SPEAKER_00: That's a lot of data.
- 11:11SPEAKER_01: It is.
- 11:12SPEAKER_01: The core debate is,
- 11:14SPEAKER_01: will we see quick cash release and buybacks or sustained spending
- 11:17SPEAKER_01: and slower distributions?
- 11:19SPEAKER_01: Right.
- 11:19SPEAKER_01: These are correlated AI perspectives waiting toward a disciplined reconciliation
- 11:24SPEAKER_01: of demand, spending, and cost revisions.
- 11:27SPEAKER_00: Here's where it gets really interesting,
- 11:29SPEAKER_00: because we need to talk about how this all plays out on the calendar.
- 11:32SPEAKER_00: The price model marks valuation checkpoints in December 2026, March 2027, and June 2027.
- 11:40SPEAKER_00: And those imply cumulative price returns around 5.8%, 8.7%, and 12.2%.
- 11:46SPEAKER_01: And I cannot emphasize this forcefully enough.
- 11:49SPEAKER_01: The quarterly price checkpoints and official operational events are two separate calendars.
- 11:54SPEAKER_01: Those December, March, and June dates are strictly points on an investment price curve.
- 11:59SPEAKER_01: They are absolutely not factory production targets.
- 12:02SPEAKER_01: They are not margin deadlines and they are not management promises.
- 12:06SPEAKER_01: A factory has no newly established June deadline just because
- 12:10SPEAKER_01: a valuation model plotted a point there.
- 12:12SPEAKER_00: That is such a vital distinction.
- 12:14SPEAKER_01: Because the actual event calendar looks very different.
- 12:16SPEAKER_00: It does.
- 12:17SPEAKER_00: The Q3 results are out today with a webcast scheduled for October 20th at 9.30 a.m.
- 12:22SPEAKER_00: Eastern Daylight Time.
- 12:24SPEAKER_00: Looking further out,
- 12:25SPEAKER_00: the Sentinel restructuring was targeted for the end of 2026 and flight testing
- 12:30SPEAKER_00: for 2027.
- 12:32SPEAKER_01: And a quick reality check on that,
- 12:33SPEAKER_01: an inert missile assembled just for testing does not count as a completed flight.
- 12:38SPEAKER_01: Production progress,
- 12:39SPEAKER_01: cash receipts,
- 12:40SPEAKER_01: and cost revisions are the actual business evidence the research uses later
- 12:44SPEAKER_01: to reassess that valuation curve.
- 12:47SPEAKER_00: It's fascinating to see how the timeline has evolved,
- 12:50SPEAKER_00: actually,
- 12:50SPEAKER_00: because back in July,
- 12:52SPEAKER_00: we saw a roughly $96 billion backlog,
- 12:55SPEAKER_00: 12 percent margins, self-funding and continuing buybacks.
- 12:59SPEAKER_01: Right.
- 12:59SPEAKER_01: Contrast that with September.
- 13:01SPEAKER_01: The backlog grew to roughly $105 billion,
- 13:04SPEAKER_01: but the evidence shifted towards sustained factory spending,
- 13:07SPEAKER_01: paused repurchases and delayed distributable cash.
- 13:11SPEAKER_00: And today we have a roughly $110 billion backlog and raised profit guidance.
- 13:17SPEAKER_00: Uneven margins and that disclosed equipment sale keep cash conversion highly relevant.
- 13:23SPEAKER_01: Yeah.
- 13:24SPEAKER_01: This evolution really reminds me of our conversation in episode 25 on Boston Scientific.
- 13:29SPEAKER_00: Oh, absolutely.
- 13:30SPEAKER_00: In that deep dive,
- 13:31SPEAKER_00: we looked at how commercial medical device demand
- 13:34SPEAKER_00: and expansion spending differ drastically from what Northrop does.
- 13:38SPEAKER_01: Yeah.
- 13:39SPEAKER_01: Northrop relies heavily on government procurement and navigating
- 13:42SPEAKER_01: the incredibly complex delivery of classified generational hardware.
- 13:47SPEAKER_01: It's a completely different beast.
- 13:49SPEAKER_01: I highly recommend you revisit our Boston Scientific,
- 13:51SPEAKER_01: SpaceX and NVIDIA conversations to contrast these different models.
- 13:55SPEAKER_00: For sure.
- 13:56SPEAKER_00: So what actually breaks the thesis for Northrop Grumman here?
- 13:59SPEAKER_00: What are the invalidations?
- 14:01SPEAKER_01: Well, the thesis weakens if we see repeated adverse cost revisions,
- 14:06SPEAKER_01: or if cash receipts slip alongside high investment,
- 14:09SPEAKER_01: or if Congress reduces appropriations for strategic programs.
- 14:13SPEAKER_01: Conversely,
- 14:14SPEAKER_01: durable program margins and repeatable cash flow after their investments strengthen
- 14:18SPEAKER_01: the thesis.
- 14:20SPEAKER_00: I know the B-21 early production is largely a fixed price setup,
- 14:24SPEAKER_00: while the central development is a cost-type contract.
- 14:27SPEAKER_00: How much does that contract structure matter?
- 14:30SPEAKER_01: Contract structures allocate risk, but they never guarantee success.
- 14:34SPEAKER_01: And it is vital to remember that
- 14:36SPEAKER_01: a higher government program budget does not automatically equal a corporate loss
- 14:40SPEAKER_01: or vice versa.
- 14:42SPEAKER_00: Right.
- 14:42SPEAKER_00: It always comes down to execution.
- 14:44SPEAKER_01: Always.
- 14:45SPEAKER_00: So what does this all mean?
- 14:46SPEAKER_00: If we zoom out, Northrop's order book is vast.
- 14:50SPEAKER_00: It covers aircraft, missiles, sensors, communications and space systems.
- 14:56SPEAKER_00: The whole backlog is not just a single bomber order,
- 14:59SPEAKER_00: and it's not solely human-piloted hardware.
- 15:01SPEAKER_01: And from the model's perspective,
- 15:03SPEAKER_01: the final verdict is that it remains a dated buy at both horizons,
- 15:07SPEAKER_01: but that label is strictly conditional on profitable delivery and cash conversion.
- 15:11SPEAKER_00: The mirage has to become water.
- 15:13SPEAKER_00: If you want to dig into the actual numbers,
- 15:15SPEAKER_00: we invite you to inspect the dated research,
- 15:17SPEAKER_00: the opinions, and the full set of assumptions for yourself over at ipulseai.com.
- 15:23SPEAKER_00: We encourage you to listen, watch,
- 15:24SPEAKER_00: or subscribe to AI Investment Edge and definitely check out our past conversations
- 15:29SPEAKER_00: on NVIDIA, SpaceX, and Boston Scientific.
- 15:32SPEAKER_01: Definitely worth a listen.
- 15:33SPEAKER_00: We are shifting gears entirely for our next deep dive,
- 15:36SPEAKER_00: moving from the defense industrial base back to healthcare.
- 15:40SPEAKER_00: Next up is Medtronic.
- 15:42SPEAKER_00: Can medical device scale and innovation improve the cash investors receive?
- 15:46SPEAKER_00: That's the big question.
- 15:47SPEAKER_00: Think on that and we'll see you next time.